Blogs

Work/study productivity gain and associated indirect cost savings with guselkumab compared with adalimumab in moderate-to-severe psoriasis: results from the VOYAGE 1 study

By Aesthetic Multispecialty Society posted Apr 16, 2020 12:48 PM

  
.
0 comments
0 views

Related Content

Permalink